KBI Biopharma is a global Contract Development and Manufacturing Organization (CDMO) providing advanced biologic solutions for the development and manufacturing of biopharmaceuticals.

KBI Biopharma, part of the JSR Life Sciences Group, is a leading CDMO offering integrated services for the development and production of biologic therapies. With a strong emphasis on next-generation technologies, KBI specializes in both mammalian and microbial systems. The company supports its clients from early-stage development through to commercial manufacturing, focusing on creating robust, scalable processes for biologics that ensure efficiency and compliance.

Key Products and Services:

• Mammalian and Microbial Cell Line Development
• Process Development (scalable and reproducible)
• Analytical Development (comprehensive testing across phases)
• Formulation Development (data-driven, optimized formulations)
• Characterization (molecule understanding through various techniques)
• Clinical Manufacturing (for biologics and vaccines)
• Commercial Manufacturing (GMP-compliant, reliable biotherapeutic supply)

KBI Biopharma’s commitment to quality, innovation, and customer-focused solutions has made it a trusted partner for biopharmaceutical companies worldwide. With cutting-edge platforms like SUREtechnology and PUREplatform, KBI ensures that its clients receive high-quality, scalable, and efficient biomanufacturing services from preclinical to commercial stages.